by Peter Kapitein | Apr 6, 2017 | In the media
JPM – Precision Medicine also mean an excellent diagnosis
by Peter Kapitein | Apr 6, 2017 | In the media
JTS – The hope of personalized medicine
by Peter Kapitein | Apr 4, 2017 | In the media
‘Good morning Mr. Smith. Good to see you, how are you doing? You’re looking for a new car? That’s good news. We decided that it’s going to be a Ford Focus, ST, 2.0 Eco-boost, 184 KW, 6-gear. Let’s see in stock if there is a possibility that you decide on the color...
by Peter Kapitein | Apr 4, 2017 | In the media
Chinese Clinical Oncology 2016 I want my Olaparib and I want it now! ‘Because I have cancer above the midriff, I can go and whistle for that drug, but it would have been given to me if the cancer had been under the midriff’. It’s an emotional outburst from a...
by Peter Kapitein | Apr 4, 2017 | In the media
Annals of Translational Medicine, 2016;4(1):22 Trials are not for the benefit of patients. They are set up to enable the pharmaceutical industry to register new drugs. And the only thing the industry needs is a drug that performs better than the one it is meant to...
